Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Colorectal Neoplasms

Free Subscription 10.01.2022 1 Adv Exp Med Biol 6 Ann Surg Oncol 3 Anticancer Res 4 BMC Cancer 1 Br J Cancer 1 Br J Surg 2 Cancer 5 Cancer Lett 2 Cancer Res 1 Clin Cancer Res 16 Dis Colon Rectum 6 Eur J Surg Oncol 2 Gastroenterology 9 Gastrointest Endosc 1 Gut 1 Int J Oncol 1 J Clin Oncol 2 J Natl Cancer Inst 6 J Pathol 1 N Engl J Med 7 Oncogene 1 Oncol Rep 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Adv Exp Med Biol

1. PANAHI Y, Saberi-Karimian M, Valizadeh O, Behnam B, et al
   Effects of Curcuminoids on Systemic Inflammation and Quality of Life in Patients with Colorectal Cancer Undergoing Chemotherapy: A Randomized Controlled Trial.
   Adv Exp Med Biol. 2021;1328:1-9.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

2. SIMUNOVIC M, Grubac V, Hillis C, Yang I, et al
   Identification and Adjudication of Adverse Events Following Rectal Cancer Surgery: Observational Case Series in a Region of Ontario, Canada.
   Ann Surg Oncol. 2022;29:1182-1191.
   PubMed         Abstract available
   
   
3. KROON HM, Dudi-Venkata NN, Bedrikovetski S, Liu J, et al
   Malignant Features in Pretreatment Metastatic Lateral Lymph Nodes in Locally Advanced Low Rectal Cancer Predict Distant Metastases.
   Ann Surg Oncol. 2022;29:1194-1203.
   PubMed         Abstract available
   
   
4. KIM JK, Thompson H, Jimenez-Rodriguez RM, Wu F, et al
   Adoption of Organ Preservation and Surgeon Variability for Patients with Rectal Cancer Does Not Correlate with Worse Survival.
   Ann Surg Oncol. 2022;29:1172-1179.
   PubMed         Abstract available
   
   
5. LEECH MM, Weiss JE, Markey C, Loehrer AP, et al
   ASO Visual Abstract: Influence of Race, Insurance, Rurality, and Socioeconomic Status on Equity of Lung and Colorectal Cancer Care.
   Ann Surg Oncol. 2022 Jan 3. pii: 10.1245/s10434-021-11247.
   PubMed        
   
   
6. VERHEIJ FS, Soares KC, Beets GL, Kok NFM, et al
   ASO Visual Abstract: Timing of Primary Tumor Resection in Synchronous Metastatic Colon Cancer Patients Undergoing Hepatic Arterial Infusion Pump Placement.
   Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11106.
   PubMed        
   
   
7. LEECH MM, Weiss JE, Markey C, Loehrer AP, et al
   Influence of Race, Insurance, Rurality, and Socioeconomic Status on Equity of Lung and Colorectal Cancer Care.
   Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11160.
   PubMed         Abstract available
   
   

   
   Anticancer Res

8. HWANG J, Park A, Kim C, Yu D, et al
   Suppression of DYRK1A/B Drives Endoplasmic Reticulum Stress-mediated Autophagic Cell Death Through Metabolic Reprogramming in Colorectal Cancer Cells.
   Anticancer Res. 2022;42:589-598.
   PubMed         Abstract available
   
   
9. MIYOSHI K, Sato E, Katsumata K, Fukushima G, et al
   CD15(+) Bone Marrow-derived Cells Are Regulators of Immune Response in ARG1-producing Colorectal Cancer Cells.
   Anticancer Res. 2022;42:459-470.
   PubMed         Abstract available
   
   
10. MULLER O, Sindayigaya R, Chomicki S, Karam E, et al
    Prognostic Impact of Upfront Surgery for Locally Advanced Upper Rectal Adenocarcinoma.
    Anticancer Res. 2022;42:155-164.
    PubMed         Abstract available
    
    

    
    BMC Cancer

11. CIUCA A, Moldovan R, Baban A
    Mapping psychosocial interventions in familial colorectal cancer: a rapid systematic review.
    BMC Cancer. 2022;22:8.
    PubMed         Abstract available
    
    
12. SHOKAR NK, Salinas J, Dwivedi A
    Mediators of screening uptake in a colorectal cancer screening intervention among Hispanics.
    BMC Cancer. 2022;22:37.
    PubMed         Abstract available
    
    
13. YIN J, Wang H, Hong Y, Ren A, et al
    Identification of an at-risk subpopulation with high immune infiltration based on the peroxisome pathway and TIM3 in colorectal cancer.
    BMC Cancer. 2022;22:44.
    PubMed         Abstract available
    
    
14. KASAHARA K, Enomoto M, Udo R, Tago T, et al
    Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study.
    BMC Cancer. 2022;22:20.
    PubMed         Abstract available
    
    

    
    Br J Cancer

15. YCHOU M, Rivoire M, Thezenas S, Guimbaud R, et al
    Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial.
    Br J Cancer. 2022 Jan 6. pii: 10.1038/s41416-021-01644.
    PubMed         Abstract available
    
    

    
    Br J Surg

16. DUELAND S, Syversveen T, Hagness M, Grut H, et al
    Liver transplantation for advanced liver-only colorectal metastases.
    Br J Surg. 2021;108:1402-1405.
    PubMed        
    
    

    
    Cancer

17. CORONADO GD
    Sustainable infrastructure and risk stratification are needed to appropriately deliver colorectal cancer screening globally.
    Cancer. 2022 Jan 5. doi: 10.1002/cncr.34059.
    PubMed        
    
    
18. SELMOUNI F, Amrani L, Sauvaget C, Bakkar M, et al
    Delivering colorectal cancer screening integrated with primary health care services in Morocco: Lessons learned from a demonstration project.
    Cancer. 2022 Jan 5. doi: 10.1002/cncr.34061.
    PubMed         Abstract available
    
    

    
    Cancer Lett

19. PIN F, Prideaux M, Huot JR, Essex AL, et al
    Non-bone metastatic cancers promote osteocyte-induced bone destruction.
    Cancer Lett. 2021;520:80-90.
    PubMed         Abstract available
    
    
20. SCHURMANN L, Schumacher L, Roquette K, Brozovic A, et al
    Inhibition of the DSB repair protein RAD51 potentiates the cytotoxic efficacy of doxorubicin via promoting apoptosis-related death pathways.
    Cancer Lett. 2021;520:361-373.
    PubMed         Abstract available
    
    
21. SHAO X, Sun S, Zhou Y, Wang H, et al
    Bacteroides fragilis restricts colitis-associated cancer via negative regulation of the NLRP3 axis.
    Cancer Lett. 2021;523:170-181.
    PubMed         Abstract available
    
    
22. HUANG M, Liu M, Huang D, Ma Y, et al
    Tumor perivascular cell-derived extracellular vesicles promote angiogenesis via the Gas6/Axl pathway.
    Cancer Lett. 2022;524:131-143.
    PubMed         Abstract available
    
    
23. TAN G, Lin C, Huang C, Chen B, et al
    Radiosensitivity of colorectal cancer and radiation-induced gut damages are regulated by gasdermin E.
    Cancer Lett. 2021;529:1-10.
    PubMed         Abstract available
    
    

    
    Cancer Res

24. GEN Y, Muramatsu T, Inoue J, Inazawa J, et al
    miR-766-5p Targets Super-Enhancers by Downregulating CBP and BRD4.
    Cancer Res. 2021;81:5190-5201.
    PubMed         Abstract available
    
    
25. FAN F, Liu P, Bao R, Chen J, et al
    A Dual PI3K/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint Therapy.
    Cancer Res. 2021;81:6233-6245.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

26. CRUZ-DUARTE R, de Almeida CR, Negrao M, Fernandes A, et al
    Predictive and therapeutic implications of a novel PLCgamma1/SHP2-driven mechanism of cetuximab resistance in metastatic colorectal cancer.
    Clin Cancer Res. 2022 Jan 3. pii: 1078-0432.CCR-21-1992.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

27. DULSKAS A, Aukstikalnis T, Kavaliauskas P, Samalavicius NE, et al
    The Role of Traditional Acupuncture in Low Anterior Resection Syndrome Treatment: A Pilot Study.
    Dis Colon Rectum. 2022;65:93-99.
    PubMed         Abstract available
    
    
28. VARELA C, Ku GY, Min BS
    Modified Complete Mesocolic Excision with Central Vascular Ligation and Intracorporeal Anastomosis for Right-Sided Colon Cancer.
    Dis Colon Rectum. 2022 Jan 4. pii: 00003453-900000000-99197.
    PubMed        
    
    
29. SAMALAVICIUS NE, Klimasauskiene V, Dulskas A
    Open Left Hemicolectomy for Proximal Sigmoid Cancer.
    Dis Colon Rectum. 2022;65:e14-e15.
    PubMed        
    
    
30. GUEVARA-MARTINEZ J, Toribio-Vazquez C, Noire FP, Cantero R, et al
    Transanal Minimally Invasive Surgery for Local Excision of a Rectal Schwannoma.
    Dis Colon Rectum. 2022;65:e1-e3.
    PubMed        
    
    
31. XIE Y, Lin J, Wang X, Wang P, et al
    The Addition of Preoperative Radiation Is Insufficient for Lateral Pelvic Control in a Subgroup of Patients With Low Locally Advanced Rectal Cancer: A Post Hoc Study of a Randomized Controlled Trial.
    Dis Colon Rectum. 2021;64:1321-1330.
    PubMed         Abstract available
    
    
32. ELSNER AT, Brosi P, Walensi M, Uhlmann M, et al
    Closure of Temporary Ileostomy 2 Versus 12 Weeks After Rectal Resection for Cancer: A Word of Caution From a Prospective, Randomized Controlled Multicenter Trial.
    Dis Colon Rectum. 2021;64:1398-1406.
    PubMed         Abstract available
    
    
33. GRECO JM, Abelson JS
    Management of Early-Stage Rectal Cancer.
    Dis Colon Rectum. 2021;64:1313-1318.
    PubMed         Abstract available
    
    
34. DE LACY FB, Turrado-Rodriguez V, Torroella A, van Laarhoven J, et al
    Functional Outcomes and Quality of Life After Transanal Total Mesorectal Excision for Rectal Cancer: A Prospective Observational Study.
    Dis Colon Rectum. 2022;65:46-54.
    PubMed         Abstract available
    
    
35. LIGHTNER AL, Vogler SA, Vaidya PS, McMichael JP, et al
    The Fate of Unifocal Versus Multifocal Low-Grade Dysplasia at the Time of Colonoscopy in Patients With IBD.
    Dis Colon Rectum. 2021;64:1364-1373.
    PubMed         Abstract available
    
    
36. NONAKA T, Tominaga T, Akazawa Y, Sawai T, et al
    Complete Endoscopic Transperineal Approach for Rectal Stump Cancer in a Patient With Crohn's Disease.
    Dis Colon Rectum. 2021;64:e656.
    PubMed        
    
    
37. PARIKH MS, Johnson P, Romanes JP, Freitag HE, et al
    Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review.
    Dis Colon Rectum. 2022;65:16-26.
    PubMed         Abstract available
    
    
38. MILANES GUISADO Y, Sotomayor C, Fontillon M, Dominguez Castano A, et al
    Incidence Rate and Risk Factors for Anal Squamous Cell Carcinoma in a Cohort of People Living With HIV from 2004 to 2017: Implementation of a Screening Program.
    Dis Colon Rectum. 2022;65:28-39.
    PubMed         Abstract available
    
    
39. YOU YN, Dasari A, Chang GJ
    Report from American Society of Clinical Oncology Symposium 2020 and American Society of Clinical Oncology Gastrointestinal Cancer Symposium 2021.
    Dis Colon Rectum. 2022;65:8-10.
    PubMed        
    
    
40. CHOUHAN H, Abbass MA, Hrabe JE, Ferrandon S, et al
    Evaluation of Urinalysis-Based Screening for Urothelial Carcinoma in Patients With Lynch Syndrome.
    Dis Colon Rectum. 2022;65:40-45.
    PubMed         Abstract available
    
    
41. MANCEAU G, Alves A, Meillat H, Benhaim L, et al
    What Is the Optimal Elective Colectomy for Splenic Flexure Cancer: End of the Debate? A Multicenter Study From the GRECCAR Group With a Propensity Score Analysis.
    Dis Colon Rectum. 2022;65:55-65.
    PubMed         Abstract available
    
    
42. ZHANG B, Zhuo GZ, Zhao K, Zhao Y, et al
    Cumulative Incidence and Risk Factors of Permanent Stoma After Intersphincteric Resection for Ultralow Rectal Cancer.
    Dis Colon Rectum. 2022;65:66-75.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

43. VAN DE VLASAKKER VCJ, Lurvink RJ, Cashin PH, Ceelen W, et al
    The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI).
    Eur J Surg Oncol. 2021;47:2888-2892.
    PubMed         Abstract available
    
    
44. BAE HW, Kim HS, Yang SY, Kim HS, et al
    Upfront chemotherapy and short-course radiotherapy with delayed surgery for locally advanced rectal cancer with synchronous liver metastases.
    Eur J Surg Oncol. 2021;47:2814-2820.
    PubMed         Abstract available
    
    
45. GAU L, Ribeiro M, Pereira B, Poirot K, et al
    Impact of BRAF mutations on clinical outcomes following liver surgery for colorectal liver metastases: An updated meta-analysis.
    Eur J Surg Oncol. 2021;47:2722-2733.
    PubMed         Abstract available
    
    
46. LJUNGGREN M, Nordenvall C, Palmer G
    Direct surgery with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastases.
    Eur J Surg Oncol. 2021;47:2865-2872.
    PubMed         Abstract available
    
    
47. GUERRA F, Petrelli F, Greco PA, Sisti V, et al
    The impact of synchronous liver resection on the risk of anastomotic leakage following elective colorectal resection. A propensity score match analysis on behalf of the iCral study group.
    Eur J Surg Oncol. 2021;47:2873-2879.
    PubMed         Abstract available
    
    
48. WARPS AK, Detering R, Tollenaar RAEM, Tanis PJ, et al
    Textbook outcome after rectal cancer surgery as a composite measure for quality of care: A population-based study.
    Eur J Surg Oncol. 2021;47:2821-2829.
    PubMed         Abstract available
    
    

    
    Gastroenterology

49. SAITO Y, Ono A
    Underwater Endoscopic Mucosal Resection for Colorectal Lesions: A Bridge Between Conventional Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection.
    Gastroenterology. 2021;161:1369-1371.
    PubMed        
    
    
50. BILLINGS W, Krigel A
    The Sulfur Microbial Diet and Micro-managing Early-Onset Colorectal Neoplasia.
    Gastroenterology. 2021;161:1366-1367.
    PubMed        
    
    

    
    Gastrointest Endosc

51. MEULEN LWT, van der Zander QEW, Bogie RMM, Keulen ETP, et al
    Evaluation of polypectomy quality indicators of large nonpedunculated colorectal polyps in a nonexpert, bowel cancer screening cohort.
    Gastrointest Endosc. 2021;94:1085-1095.
    PubMed         Abstract available
    
    
52. SHIMAMOTO Y, Ishiguro S, Takeuchi Y, Nakatsuka SI, et al
    Gastric neoplasms in patients with familial adenomatous polyposis: endoscopic and clinicopathologic features.
    Gastrointest Endosc. 2021;94:1030-1042.
    PubMed         Abstract available
    
    
53. LIVOVSKY DM, Veikherman D, Golany T, Aides A, et al
    Detection of elusive polyps using a large-scale artificial intelligence system (with videos).
    Gastrointest Endosc. 2021;94:1099-1109.
    PubMed         Abstract available
    
    
54. FARHA N, Hrabe J, Sleiman J, Beard J, et al
    Clinically actionable findings on surveillance EGD in asymptomatic patients with Lynch syndrome.
    Gastrointest Endosc. 2022;95:105-114.
    PubMed         Abstract available
    
    
55. VEMULAPALLI KC, Lahr RE, Lee CJ, Abdullah N, et al
    Yield of a second right colon examination during colonoscopy after a first examination using a mucosal exposure device.
    Gastrointest Endosc. 2022;95:149-154.
    PubMed         Abstract available
    
    
56. JAIN A, Alimirah M, Stanich PP
    Upper GI tract screening in Lynch syndrome.
    Gastrointest Endosc. 2022;95:202.
    PubMed        
    
    
57. MANKANEY G, Cruise M, Burke CA
    Finding the needle in a haystack: approach to detection of high-risk gastric lesions in familial adenomatous polyposis.
    Gastrointest Endosc. 2021;94:1043-1045.
    PubMed        
    
    
58. ISHIYAMA M, Kudo SE, Misawa M, Mori Y, et al
    Impact of the clinical use of artificial intelligence-assisted neoplasia detection for colonoscopy: a large-scale prospective, propensity score-matched study (with video).
    Gastrointest Endosc. 2022;95:155-163.
    PubMed         Abstract available
    
    
59. RABINOWITZ LG, Kumta NA, Marion JF
    Beyond the SCENIC route: updates in chromoendoscopy and dysplasia screening in patients with inflammatory bowel disease.
    Gastrointest Endosc. 2022;95:30-37.
    PubMed        
    
    

    
    Gut

60. GRANT RC, Denroche R, Jang GH, Nowak KM, et al
    Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma.
    Gut. 2020 Sep 15. pii: gutjnl-2020-320730. doi: 10.1136/gutjnl-2020-320730.
    PubMed         Abstract available
    
    

    
    Int J Oncol

61. WANG J, Yokoyama Y, Hirose H, Shimomura Y, et al
    Functional assessment of miR1291 in colon cancer cells.
    Int J Oncol. 2022;60.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

62. CHENG E, Ou FS, Ma C, Spiegelman D, et al
    Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance).
    J Clin Oncol. 2022 Jan 7:JCO2101784. doi: 10.1200/JCO.21.01784.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

63. GIOVANNUCCI E
    Molecular Biologic and Epidemiologic Insights for Preventability of Colorectal Cancer.
    J Natl Cancer Inst. 2022 Jan 3. pii: 6493343. doi: 10.1093.
    PubMed         Abstract available
    
    
64. SHANKARAN V, Unger JM, Darke AK, Suga JM, et al
    S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients.
    J Natl Cancer Inst. 2022 Jan 4. pii: 6492636. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Pathol

65. KRAUSE J, Grabsch HI, Kloor M, Jendrusch M, et al
    Deep learning detects genetic alterations in cancer histology generated by adversarial networks.
    J Pathol. 2021;254:70-79.
    PubMed         Abstract available
    
    
66. ONUMA K, Sato Y, Okuyama H, Uematsu H, et al
    Aberrant activation of Rho/ROCK signaling in impaired polarity switching of colorectal micropapillary carcinoma.
    J Pathol. 2021;255:84-94.
    PubMed         Abstract available
    
    
67. CHARLES CAMPBELL F
    Untangling the complexities of micropapillary cancer(dagger).
    J Pathol. 2021;255:343-345.
    PubMed         Abstract available
    
    
68. SCHRAMMEN PL, Ghaffari Laleh N, Echle A, Truhn D, et al
    Weakly supervised annotation-free cancer detection and prediction of genotype in routine histopathology.
    J Pathol. 2022;256:50-60.
    PubMed         Abstract available
    
    
69. CERRETELLI G, Zhou Y, Muller MF, Adams DJ, et al
    Ethanol-induced formation of colorectal tumours and precursors in a mouse model of Lynch syndrome.
    J Pathol. 2021;255:464-474.
    PubMed         Abstract available
    
    
70. KIM JH, Hong JH, Choi YL, Lee JA, et al
    NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
    J Pathol. 2021;255:399-411.
    PubMed         Abstract available
    
    

    
    N Engl J Med

71. HORN DM, Haas JS
    Expanded Lung and Colorectal Cancer Screening - Ensuring Equity and Safety under New Guidelines.
    N Engl J Med. 2022 Jan 8. doi: 10.1056/NEJMp2113332.
    PubMed        
    
    

    
    Oncogene

72. XU H, Wong CC, Li W, Zhou Y, et al
    RING-finger protein 6 promotes colorectal tumorigenesis by transcriptionally activating SF3B2.
    Oncogene. 2021;40:6513-6526.
    PubMed         Abstract available
    
    
73. WANG S, Wong CC, Zhang Y, Huang J, et al
    ZNF545 loss promotes ribosome biogenesis and protein translation to initiate colorectal tumorigenesis in mice.
    Oncogene. 2021;40:6590-6600.
    PubMed         Abstract available
    
    
74. POLOSUKHINA D, Singh K, Asim M, Barry DP, et al
    CCL11 exacerbates colitis and inflammation-associated colon tumorigenesis.
    Oncogene. 2021;40:6540-6546.
    PubMed         Abstract available
    
    
75. CAO CH, Ling H, Han K, Lu XP, et al
    PPIP5K2 promotes colorectal carcinoma pathogenesis through facilitating DNA homologous recombination repair.
    Oncogene. 2021;40:6680-6691.
    PubMed         Abstract available
    
    
76. LI Z, He Y, Li Y, Li J, et al
    NeuroD1 promotes tumor cell proliferation and tumorigenesis by directly activating the pentose phosphate pathway in colorectal carcinoma.
    Oncogene. 2021;40:6736-6747.
    PubMed         Abstract available
    
    
77. ZHENG D, Cao M, Zuo S, Xia X, et al
    Correction: RANBP1 promotes colorectal cancer progression by regulating pre-miRNA nuclear export via a positive feedback loop with YAP.
    Oncogene. 2022 Jan 4. pii: 10.1038/s41388-021-02152.
    PubMed        
    
    
78. LIN J, Xia L, Oyang L, Liang J, et al
    The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity.
    Oncogene. 2022 Jan 8. pii: 10.1038/s41388-021-02148.
    PubMed         Abstract available
    
    

    
    Oncol Rep

79. LI Y, Qian X, Lin Y, Tao L, et al
    Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment.
    Oncol Rep. 2021;46.
    PubMed         Abstract available
    
    

    
    PLoS One

80. DAEMEN A, Udyavar AR, Sandmann T, Li C, et al
    Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B.
    PLoS One. 2021;16:e0262198.
    PubMed         Abstract available
    
    
81. SIEGEL EM, Ajidahun A, Berglund A, Guerrero W, et al
    Genome-wide host methylation profiling of anal and cervical carcinoma.
    PLoS One. 2021;16:e0260857.
    PubMed         Abstract available
    
    
82. ASTARITA JL, Keerthivasan S, Husain B, Senbabaoglu Y, et al
    The neutrophil protein CD177 is a novel PDPN receptor that regulates human cancer-associated fibroblast physiology.
    PLoS One. 2021;16:e0260800.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: